Previously, pre- and postoperative abnormal serum CEA levels in CRC patients have been documented as predictors of deeper local invasion of tumours, higher risk of occult metastases or higher rates of postoperative relapse (McCall et al, 1994; Wiratkapun et al, 2001). This evidence concerns the gene CEACAM5 and colorectal carcinoma.